FibroGen, Inc.
FGEN
$10.48
$0.131.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 53.56M | 53.21M | 75.83M | -1.12M | -7.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.56M | 53.21M | 75.83M | -1.12M | -7.32M |
| Cost of Revenue | 43.41M | 69.96M | 118.36M | 167.81M | 206.24M |
| Gross Profit | 10.15M | -16.75M | -42.53M | -168.92M | -213.56M |
| SG&A Expenses | 41.06M | 48.91M | 57.52M | 44.63M | 52.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.47M | 118.87M | 175.88M | 212.44M | 258.89M |
| Operating Income | -30.91M | -65.66M | -100.05M | -213.55M | -266.20M |
| Income Before Tax | -56.27M | -89.88M | -122.15M | -208.63M | -255.09M |
| Income Tax Expenses | -76.00K | -265.00K | -260.00K | -437.00K | -365.00K |
| Earnings from Continuing Operations | -56.20 | -89.61 | -121.89 | -208.20 | -254.73 |
| Earnings from Discontinued Operations | 54.13M | 79.60M | 74.31M | 47.66M | 47.66M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.07M | -10.01M | -47.58M | -121.79M | -168.32M |
| EBIT | -30.91M | -65.66M | -100.05M | -213.55M | -266.20M |
| EBITDA | -29.27M | -63.46M | -97.36M | -209.34M | -260.35M |
| EPS Basic | -0.52 | -2.53 | -12.00 | -30.66 | -42.60 |
| Normalized Basic EPS | -5.62 | -10.96 | -16.13 | -34.02 | -42.35 |
| EPS Diluted | -0.52 | -2.53 | -12.00 | -30.66 | -42.60 |
| Normalized Diluted EPS | -5.62 | -10.96 | -16.13 | -34.02 | -42.35 |
| Average Basic Shares Outstanding | 16.13M | 16.09M | 16.01M | 15.87M | 15.77M |
| Average Diluted Shares Outstanding | 16.13M | 16.09M | 16.01M | 15.87M | 15.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |